Not a traditional drug phase: Blood samples collection for Acne

What this phase means

This is an observational study. You are not assigned a new experimental drug. Researchers measure what already happens in your care or in daily life.

Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

What the registry says happens

This listing is observational (StudyType). The registry does not assign a new experimental drug as the study intervention.

They plan to enroll about 500 people at Montreal. Taking part typically means a procedure as part of the study plus check-ins.

Official title (unrewritten)

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers for Molecular Characterization of Inflammatory Skin Diseases

Interventions: Blood samples collection, Oral samples collection, Hair samples collection, Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping), Skin surface material samples, Drainage fluid samples collection, Stool samples collection

Primary outcome (registry wording): Untargeted biomarker approach with gene expression profile of skin samples

Who it is for (from inclusion criteria)

• Ages 18 Years to any
• Healthy volunteers:
• Male or female subject aged 18 years or older, at the time of consent
• Subject is in good general health, according to the investigator's judgment
• Subjects with Acne:
• Male or female subject aged 18 to 45 years old, inclusive, at the time of consent
• Subject has clinically confirmed diagnosis of active AD, according to Hanifin and Rajka criteria
• Subject has at least a 6-month history of CHE before Screening (information obtained from medical chart or subject's physician, or directly from the subject)